Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
33 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsAlexion and Halozyme Enter License Agreement for ENHANZE Technology
(World News USA)

 
 

7 december 2017 13:39:35

 
Alexion and Halozyme Enter License Agreement for ENHANZE Technology
(World News USA)
 


NEW HAVEN, Conn. & SAN DIEGO--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced today a collaboration and license agreement that enables Alexion to use Halozyme`s ENHANZE drug-delivery technology in the development of subcutaneous formulations for their portfolio of products. The agreement provides Alexion with the opportunity for exclusive development of up to four targets, including a next generation subcutaneous formulation of ALXN1210 (ALXN1210 SC), the company`s investigational long-acting C5 complement inhibitor, to potentially further extend the dosing interval of ALXN1210 SC to once every two weeks or once per month....


 
20 viewsCategory: General > North America > USA
 
Sherpa`s Sponsors AmCham Shanghai`s 16th Annual Appreciation Dinner
(World News USA)
Asked and Answered: Dec. 7
(World News USA)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten